Nearly 40% of ischaemic strokes remain cryptogenic when no clear aetiology is identified after a thorough initial investigation. Two recent articles in Stroke described extended arrhythmia monitoring modalities to reveal paroxysmal atrial fibrillation in patients with ischaemic stroke, with implications for decisions regarding anticoagulation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Liao, J., Khalid, Z., Scallan, C., Morillo, C. & O'Donnell, M. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke 38, 2935–2940 (2007).
Hart, R. G. et al. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J. Am. Coll. Cardiol. 35, 183–187 (2000).
Marini, C. et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 36, 1115–1119 (2005).
Barthélémy, J. C. et al. Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks. Ann. Noninvasive Electrocardiol. 8, 194–199 (2003).
Jabaudon, D., Sztajzel, J., Sievert, K., Landis, T. & Sztajzel, R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 35, 1647–1651 (2004).
Flint, A. C. et al. Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) registry. Stroke 43, 2788–2790 (2012).
Rizos, T. et al. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke 43, 2689–2694 (2012).
Ip, J. et al. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with ICD and CRT-D devices: rationale, design and clinical characteristics of the initially enrolled cohort: the IMPACT Study. Am. Heart J. 158, 364–370e1 (2009).
de Vos, C. B. et al. Progression from paroxysmal to persistent atrial fibrillation: clinical correlates and prognosis. J. Am. Coll. Cardiol. 55, 725–731 (2010).
Sinha, A. M. et al. Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale. Am. Heart J. 160, 36–41 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J. L. Halperin has received consulting fees from Bayer AG HealthCare, Boehringer Ingelheim, Daiichi Sankyo, Johnson & Johnson, Janssen Pharmaceuticals, Pfizer and Sanofi-Aventis for advisory activities involving the development of new anticoagulant drugs. He receives consulting fees from Biotronik, Inc. as Co-Chairman of the Steering Committee for the IMPACT clinical trial and from Medtronic as a member of the Steering Committee of the REVEAL-AF study. He served on the Operations Committee for the PALLAS clinical trial, sponsored by Sanofi-Aventis. He serves on the Executive Steering Committee of the GLORIA-AF Registry, sponsored by Boehringer Ingeheim, and as Chairman of the Data and Safety Monitoring Committee for a clinical trial comparing ticagrelor and clopidogrel for prevention of major adverse cardiovascular events in patients with peripheral arterial disease, sponsored by AstraZeneca. D. Pain declares no competing interests.
Rights and permissions
About this article
Cite this article
Pain, D., Halperin, J. Finding atrial fibrillation after cryptogenic stroke. Nat Rev Neurol 8, 666–667 (2012). https://doi.org/10.1038/nrneurol.2012.228
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2012.228